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therapist for their knee at one and two years (Table). All of these contrasts
were highly statistically signiﬁcant (p < 0.001).
Conclusions: TKR recipients with severe knee pain in the early
months following surgery have much greater functional deﬁcits and
dissatisfaction with the results of surgery at one, two and ﬁve
year follow-up than patients with less severe pain in the early
months following TKR. These data highlight the health and economic
consequences of severe, persistent pain following TKR. The ﬁndings
underscore the potential value of optmimizing patient selection and
of identifying patients at risk and implementing interventions to reduce
the frequency of severe pain in the early months following TKR.
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Purpose: To analyze the effect of published exercise therapy programs
aimed at reducing pain in patients with osteoarthritis (OA) in the knee,
in order to identify the most optimal exercise program characterized
by number of supervised sessions, type of exercise, relative exercise
intensity and duration of exercise sessions.
Methods: A systematic review and meta-analysis based on published
exercise studies identiﬁed by a comprehensive literature was performed.
Eligible were randomized controlled trials comparing any exercise
intervention with a sham or non-intervention control in patients with
knee OA, using a least one patient reported outcome on pain. Effect sizes
were calculated as standardized mean differences (SMD) estimated from
differences in mean changes between intervention- and control group
after an exercise program, divided by the pooled standard deviation.
SMDs were combined by using a random effects meta-analysis model;
incl. both 95% conﬁdence intervals and prediction intervals. Stratiﬁed
analyses and meta-regression analyses were used to examine study-level
covariates.
Results: Forty one trials with 3274 patients with knee OA comparing 48
interventions with controls were included in the analyses. The pooled
SMD for the reduction of pain was 0.48 [95% CI: 0.36; 0.60] in favor
of exercise, although based on a large between study inconsistency
(I2= 58%). Interpreting this heterogeneity, the 95% prediction interval
(−0.14; 1.10) contains values below 0 and so, although on average the
intervention seems effective, it may not always be beneﬁcial in an
individual setting.
Focusing on pain in pre-speciﬁed stratiﬁed analyses showed almost
similar effects for programs aiming at improving muscle strength, aerobic
capacity or functional performance (SMD[pain]: 0.56, 0.67, and 0.49,
respectively, P = 0.822; pooled SMD= 0.57 [95% CI: 0.44; 0.69], I2= 53%).
Whereas combined programs were less effective in reducing pain (SMD
[pain]: 0.14 [95%CI: −0.11; 0.40], I2=58%), with a statistically signiﬁcant
difference (P < 0.001) between exercise subgroups SMD= 0.43 [95% CI:
0.31; 0.54] in favor of using only one type of exercise.
Heterogeneity in aerobic exercise trials could be explained in a meta-
regression model using numbers of supervised sessions. The reduction
of pain (beta-coefﬁcient = 0.026, [95% CI: 0.01–0.05], I2=23%), was
signiﬁcantly increased with a larger number of supervised exercise
sessions. In resistance exercise heterogeneity could not be explained by
study-level covariates. Stratiﬁed analyses for pain showed larger effect
when focusing on quadriceps strengthening only compared to lower limb
strengthening or strengthening the whole body (SMD[pain]: 0.72, 0.42
respectively, P = 0.04).
Conclusions: Exercise programs have on average a moderate effect for
reducing pain in knee osteoarthritis trials. However, inconsistency across
studies suggests that it will not always imply beneﬁt in comparison
with a matched control group. Stratiﬁed analyses provide evidence that
exercise programs aiming at improving strength, aerobic capacity or
functional performance are more efﬁcacious than combined exercise
programs. While the number of supervised sessions may enhance the
beneﬁts of the aerobic exercise, focusing on the quadriceps only, may
increase beneﬁts of resistance training.
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THE ARCOGEN GENOME-WIDE ASSOCIATION STUDY
K. Panoutsopoulou, on behalf of the arcOGEN Consortium and the
replication studies. Wellcome Trust Sanger Inst., Hinxton, United Kingdom
Purpose: To enable a well-powered genome-wide association study
(GWAS) for osteoarthritis (OA), we have formed the arcOGEN Consortium,
a UK-wide collaboration, and have carried out the largest GWAS to date
in 7,410 knee and/or hip OA cases and 11,009 controls.
Methods: OA cases were ascertained based on radiographic evidence of
disease (Kellgren-Lawrence grade ≥2) or clinical evidence of disease to
a level requiring total joint replacement (TJR) and were genotyped on
the Illumina Human610 platform. The study used two different types
of controls: 11,009 population-based, unrelated UK controls which came
from 5 distinct sources (the 1958 Birth Cohort and the UK Blood Donor
Service from the Wellcome Trust Case Control Consortium 2 study, the
1958 Birth Cohort from the T1DGC study, the ALSPAC study and the PoBI
study) genotyped on a variety of Illumina platforms; and 1,828 unrelated,
disease-free controls from the TwinsUK cohort (females only) genotyped
on the Illumina Human610 platform. Analyses were also performed
stratifying the cases by severity, i.e., total joint replacement (TJR) and
by joint and gender. We took forward 129 signals with p < 10−5 and
good quality control properties for in silico replication in 5 other GWAS
(deCODE, EGCUT, GARP, Rotterdam RS1 and RS2 cohorts, and TwinsUK
comprising a total of 5,064 cases and 40,619 controls) and based on these
results we prioritized 26 SNPs with p < 5×10−6 for de novo replication in
2,409 additional arcOGEN cases and 2,319 population-based controls.
Results: Following large-scale replication we have identiﬁed 5 loci
to be associated with OA at the genome-wide signiﬁcance threshold
(p < 5×10−8). The most highly associated SNP, rs6976 in the TJR analysis
(OR for the T allele = 1.12 [1.08–1.16] p =7.2×10−11) is located in
chr3p21.1, a gene-rich region. Three other genome-wide signiﬁcant
signals (rs4836732, rs9350591 and rs10492367) lie in regions/genes
with no apparent role in OA, while rs835487 (association of G allele
with total hip replacement: OR= 1.13 [1.09–1.18] p =1.6×10−8) is located in
intron 2 of the chondroitin 4 sulfotransferase 11, involved in chondrocyte
development during cartilage morphogenesis. We also report association
of rs8044769 at the FTO locus with OA in females, p = 6.85×10−8. It
appears that the FTO SNP exerts its effect on OA through obesity since
the signal is attenuated after adjustment for BMI.
Conclusions: We have identiﬁed ﬁve novel OA loci conferring modest
risk for OA. Functional studies will be needed to identify the underlying
causative genes and understand their involvement in the aetiology
of OA.
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Purpose: We aimed to assess OA susceptibility candidate genes deﬁned
according to previous genetic research in a metaanalysis of 8 genome-
wide association scans (GWAS) performed in subjects of European
ancestry.
Methods: OA susceptibility candidate genes were identiﬁed under the
OA, spinal osteophytosis and invertebral disk displacement phenotypes
in HuGE Navigator, which is a continuously updated knowledge base
in human genome epidemiology. Map positions of loci encompassing
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OA candidate genes including 50 kb of ﬂanking sequence to either
side were obtained from Ensembl. Autosomal SNPs with minor allele
frequency (MAF) in Europeans >5% and mapping to these sequences
were extracted from HapMap. Fixed effect meta-analysis across 8 OA
GWAS was performed for these SNPs. Signiﬁcance threshold was set
after Bonferroni correction for the effective number of independent test
determined with the simpleM method.
Fig. 1.
Results: A total of 186 OA candidate genes including 24298 SNPs were
analyzed in GWAS results from 5630 subjects with knee OA, 5180
with hip OA and 31272 controls. This allowed 0.8 power to detect
association of a SNP with O.R. = 1.14 and 0.2 MAF at the P < 2.2
×10−5 signiﬁcance threshold calculated for this study. Nine SNPs in the
7q22 OA locus were signiﬁcantly associated with knee OA. The most
highly associated SNP in this locus, rs4730250, has already shown GWAS
level signiﬁcant association in a previous study. There were also seven
COL11A1 SNPs associated with hip OA. They represent, at least, two
independent association signals suggesting the presence of multiple
causal polymorphisms in this gene (labelled in blue and in red in
Figure 1).
Gender stratiﬁed analyses showed association of 17 SNPs in GDF5 (top
SNP rs224329, P =1.2×10−5) with knee OA in females and of rs833058 in
VEGF with hip OA in males (P = 1.3×10−5).
Conclusions: We have found that only a small fraction of OA candidate
genes were conﬁrmed in our meta-analysis, which is the largest done to
date. This is a common ﬁnding in complex diseases. Two of the loci, 7q22
and GDF5, were already widely recognized as truthfully involved in OA
and our analysis did not identify new signals in them. The other two loci
were not renowned in genetics. However, they are particularly interesting
because of the functional implications of VEGF , which is well known
for promoting angiogenesis, and for the possibility of multiple causal
polymorphisms in COL11A1, which codes for one of the chains of type XI
collagen that is involved in maintaining cartilage integrity and cohesion.
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IDENTIFICATION OF INTERLEUKIN-16 AS A NOVEL
EPIGENETICALLY-REGULATED FACTOR IN CHONDROGENIC
DIFFERENTIATION OF ADULT STEM CELLS
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of Ireland Galway, Galway, Ireland; 2Univ. de Zaragoza, Zaragoza, Spain;
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Purpose: As mesenchymal stem cells (MSCs) differentiate they undergo
epigenetic changes. We hypothesized that elucidation of changes such as
alterations in DNA methylation would lead to increased understanding of
differentiation along speciﬁc lineages. DNA methylation is an epigenetic
process whereby methyl groups are added to cytosine residues (CpG)
typically resulting in reduced gene expression. The aim of this project
was to investigate global changes in gene promoter methylation patterns
as MSCs differentiated down various lineages and thereby identify
differentially methylated genes associated with speciﬁc differentiation
pathways.
Methods: Genomic DNA was extracted from undifferentiated,
chondrogenic, osteogenic and adipogenic MSCs at 14 days and analysed
for changes in promoter methylation patterns using a high throughput
epigenomic discovery platform with custom CpG island arrays (Inﬁnium
Human Methylation 27BeadChip Assay). 28K CpG probes were used to
analyze gene promoter regions of 14K genes yielding beta values ranging
from 0–1 depending on level of promoter methylation (0=unmethylated,
1=methylated). Stringent selection criteria were applied to the data
generated to select genes for further study. RNA was extracted from
undifferentiated and differentiated MSCs at 0, 2, 4, 7 and 14 days and
quantitative RT-PCR performed to validate array results and investigate
temporal gene expression levels of selected targets. Protein levels were
determined by Western Blotting or ELISA.
Fig. 1. (A) Heat map of representative genes illustrating relative
hypomethylation of undifferentiated MSC promoter regions in
comparison to differentiated MSCs. Scatter plots showing clustering of
undifferentiated MSC methylation patterns to those of (B) chondrocytes,
(C) osteocytes and (D) adipocytes.
Results: Analysis of the methylation patterns indicated that promoters
of undifferentiated MSCs were generally hypomethylated in agreement
with the comparatively unrestricted gene expression of these cells
(Figure 1A). Chondro- and osteo-differentiated MSC clustered closer
than to undifferentiated MSC or to adipogenic progeny, with the latter
two groups showing the least similarity (Figure 1B-D). Lineage-speciﬁc,
differentially methylated genes were selected to create differentiation-
speciﬁc methylation signatures for validation by qRT-PCR and bisulphite
sequencing. This analysis showed that DNA methylation contributed
to the rapid down regulation of superﬂuous genes on commitment
to a speciﬁc lineage whereas hypomethylation of speciﬁc CpGs was
associated with upregulation of genes associated with the differentiation
process. Based the stringent selection criteria, 15 genes (9 chondro-,
4 adipo- and 2 osteo-speciﬁc) were selected for array validation and
further study. Of the chondrogenic genes chosen, 8 were hypomethylated
following differentiation and one hypermethylated. Five of the genes
showed changes in gene expression corresponding to their methylation
signature. Of the four validated hypomethylated genes, MIA/CD-RAP and
SCRG1 have been previously associated with chondrogenesis whereas
Interleukin 16 (IL16) was identiﬁed as a novel hypomethylated factor in
chondrogenesis of MSCs. Expression of this cytokine mimicked that of
CD-RAP increasing expression over the ﬁrst 7 days of chondrogenesis
and thereafter decreasing; gene expression was rapidly downregulated
on differentiation to the adipo- and osteo- lineages. IL16 protein was
